Диссертация (1141206), страница 23
Текст из файла (страница 23)
et al. Adverse effects ofantenatal glucocorticoids on cerebral myelination in sheep // Obstet. Gynecol. —2009. –Vol. 113. — P.142–151.73.Ashwood P.J., Crowther C.A., Willson K.J. et al. Neonatal adrenalfunction after repeat dose prenatal corticosteroids: a randomized controlled trial //Am. J. Obstet.
Gynecol. — 2006. — Vol. 194. — P.861–867.74.Bale T.L. Sex differences in prenatal epigenetic programming of stresspathways // Stress. — 2011. — Vol. 14. — P.348–356.75.Ballard P.L., Granberg P., Ballard R.A. Glucocorticoid levels inmaternal and cord serum after prenatal betamethasone therapy to preventrespiratory distress syndrome // J. Clin. Invest. — 1975.
— Vol. 56. — P.1548–1554.76.Banjanin S., Kapoor A., Matthews S.G. Prenatal glucocorticoidexposure alters hypothalamicpituitary–adrenal function and blood pressure inmature male guinea pigs // J. Physiol. — 2004. — Vol. 558. — P.305–318.77.Barker D.J. Fetal Programming of Coronary Heart Diseases // TrendsEndocrinol. Metab. — 2002. — Vol. 13. — P. 364–368.78.Bartley K.A., UnderwoodB.A., Deckelbaum R.J.A life cyclemicronutrient perspective for women's health // Am. J. Clin. Nutr. — 2005.
—Vol.81. — P.1188–1193.79.Behrman H.R., Endo T., Aten R.F. Corpus luteum function andregression // Reprod. Med. Rev. — 1993. — Vol.2. — P.153–180.80.Berger P., Schwarz S., Spotti G. Variants of human chorionicgonadotropin from pregnant women and tumor patients recognized — by136monoclonal antibodies // J. Clin. Endocribol. Metab.
— 1993. — Vol.77. —P.347–351.81.Bertram C., Khan O., Ohri S. et al. Transgenerational effects ofprenatal nutrient restriction on cardiovascular and hypothalamic–pituitary–adrenalfunction // J. Physiol. — 2008. — Vol. 586.– P.2217–2229.82.Bevilacqua E., Brunelli R., Anceschi M.M. Review and meta–analysis: Benefits and risks of multiple courses of antenatal corticosteroids // J.Matern. Fetal. Neonatal.
Med. — 2010. — Vol. 23. — P.244–260.83.Braun T., Li S., Sloboda D.M. et al. Effects of maternaldexamethasone treatment in early pregnancy on pituitary–adrenal axis in fetalsheep // Endocrinology. — 2009. — Vol. 150. — P.5466–5477.84.BrownfootF.C.,CrowtherC.A.,MiddletonP.Differentcorticosteroids and regimens for accelerating fetal lung maturation for women atrisk of preterm birth // Cochrane Database Syst Rev. — 2008.
— CD006764.85.Bukowski R., Davis K., Meyer P. Folate blood concentrations and riskof preterm birth // Am. J. Obstet. Gyn. — 2009. — Vol. 201, № 6. Suppl. — P.18.86.Burstein R., Wasserman H.C. The effect of provera on the fetus //Obstet. Gynecol. — 1964. — Vol.23. — P.931–934.87.Carmichael S.L., Shaw G.M., Laurent C. et al. Maternal progestinintake and risk of hypospadias // Arch. Pediatr. Adolesc.
Med. — 2005. –Vol.159(10). — P.957–962.88.Carp H. A systematic review of dydrogesterone for the treatment ofthreatened miscarriage // Gynecol Endocrinol. — 2012. — Vol. 28, № 12. —P.983–990.89.Charalampopoulos I., Remboutsika E., Margioris A.N. et al.Neurosteroids as modulators of neurogenesis and neuronal survival // TrendsEndocrinol Metab. — 2008.
— Vol. 19, №8. — P 300–307.13790.Chatterjee A., Chatterjee R. How little luteal tissue of rats is needed tomaintain pregnancy till term an experimental verification // Acta Anat. Basel. —1992. — Vol. 144, № 4. — P. 329–331.91.Check J.H., Rankin A., Teichman M. The risk of fetal anomalies as aresult of progesterone therapy during pregnancy // Fertil Steril. — 1986. — Vol.45.— P.575–577.92.Chen Q.J., Xiang W.P., Zhang D.K. et al. Efficacy and safety of alevonorgestrel enteric–coated tablet as an over–the–counter drug for emergencycontraception: a Phase IV clinical trial // Hum.
Reprod. — 2011. — Vol. 26. —P.2316—2321.93.Cheng L., Gülmezoglu A.M., Piaggio G. et al. Interventions foremergency contraception // Cochrane Database Syst. Rev. — 2008. — Vol.2. —CD001324.94.Chrousos G.P., Kino T. Glucocorticoid signaling in the cell.Expanding clinical implications to complex human behavioral and somaticdisorders // Ann. Ny Acad. Sci. — 2009. — Vol. 1179.
— P. 153–166.95.Chrousos G.P., Gold P.W. The concepts of stress and stress systemdisorders. Overview of physical and behavioral homeostasis // JAMA. — 1992. —Vol. 267. — P. 1244–1252.96.Clark D.A. Shall we properly re–examine the status of allogeneiclymphocyte therapy for recurrent early pregnancy failure? // Am. J. Reprod.Immunol. — 2004. — Vol.51.
— P. 7—15.97.Coe C.L., Lubach G.R. Developmental consequences of antenataldexamethasone treatment in nonhuman primates // Neurosci Biobehav. R. — 2005.— Vol. 29. — P.227–235.98.Costa S., Zecca E., De Luca D. et al. Efficacy of a single dose ofantenatal corticosteroids on morbidity and mortality of preterm infants // Eur. J.Obstet. Gynecol. Reprod. Biol. — 2007. — Vol. 131. — P.154–157.99.Cox J.T., Phelan S.T. Prenatal nutrition: special considerations //Minerva Ginecol. — 2009. — Vol.61 (5). — P.373–400.138100.
Cramer D.W., Wise L.A. The epidemiology of recurrent pregnancyloss // Semin. Reprod. Med. — 2000. –Vol.18 (4). — P.331—339.101. Crosignani P.G. Management of hiperprolactinemia in infertility // J.Reprod. Med. — 1999. — Vol. 44 (12 Suppl.). — P. 1116—1120.102. Crowley P., Chalmers I., Keirse M.J. The effects of corticosteroidadministration before preterm delivery: an overview of the evidence fromcontrolled trials // Brit. J. Obstet. Gynaeс. — 1990. — Vol.
97. — P.11–25.103. Crowther C.A., Harding J.E. Repeat doses of prenatal corticosteroidsfor women at risk of preterm birth for preventing neonatal respiratory disease //Cochrane Database Syst Rev. — 2007. — CD003935.104. Crowther C.A., Mckinlay C.J., Middleton P., Harding J.E. Repeatdoses of prenatal corticosteroids for women at risk of preterm birth for improvingneonatal health outcomes //Cochrane Database Syst. Rev.— 2011. —:CD003935.105.
Croxatto H.B., Devoto L., Durand M. et al. Mechanism of action ofhormonal preparations used for emergency contraception: a review of the literature// Contraception. — 2001. — Vol. 63. — P.111–121.106. Czeizel A., Toth J., Erodi E. Aetiological studies of hypospadias inHungary // Hum. Hered. — 1979. — Vol.29. — P.166–171.107. Dalton K. The effect of progesterone and progestagens on the featus //Neurofarmacology. — 1981.
— Vol. 20, № 1213. — P. 1267–1269.108. Dalziel S.R., Walker N.K., Parag V. et al. Cardiovascular risk factorsafter antenatal exposure to betamethasone: 30–year follow–up of a randomisedcontrolled trial // Lancet. — 2005. — Vol. 365. — P.1856–1862.109. Davis E.P., Townsend E.L., Gunnar M.R. et al. Effects of prenatalbetamethasone exposure on regulation of stress physiology in healthy prematureinfants // Psychoneuroendocrinol. — 2004. — Vol. 29. — P.1028–1036.110. Davis E.P., Townsend E.L., Gunnar M.R.
et al. Antenatalbetamethasone treatment has a persisting influence on infant HPA axis regulation //J. Perinatol. — 2006. — Vol.26.– P.147–153.139111. Davis E.P., Sandman C.A. The timing of prenatal exposure tomaternal cortisol and psychosocial stress is associated with human infant cognitivedevelopment // Child Dev. — 2010. — Vol. 81. — P.131–148.112. Davis E.P., Glynn L.M., Waffarn F., Sandman C.A. Prenatal maternalstress programs infant stress regulation // J. Child Psychol. Psychiatry.
— 2011.— Vol. 52. — P.119–129.113. Davis E.P., Waffarn F., Sandman C.A. Prenatal treatment withglucocorticoids sensitizes the HPA axis response to stress among full–term infants// Dev. Psychobiol. — 2011. — Vol.53. — P.175–183.114. De Santis M., Cavaliere A.F., Straface G. et al. Failure of theemergency contraceptive levonorgestrel and the risk of adverse effects inpregnancy and on fetal development: an observational cohort study // Fertil. Steril.— 2005.
— Vol. 84. — P.296–299.115. De Vries A., Holmes M.C., Heijnis A. et al. Prenatal dexamethasoneexposure induces changes in nonhuman primate offspring cardiometabolic andhypothalamic–pituitary–adrenal axis function // J. Clin. Invest.— 2007.–Vol.117. — P.1058–1067.116. Díaz–Cueto L., Barrios–de–Tomasi J., Timossi C. et al. More invitrobioactive, shorter–lived human chorionic gonadotrophin charge isoforms increaseat the end of the first and during the third trimesters of gestation // Mol. Hum.Reprod.